Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep 1;144(3):627-43.
doi: 10.1084/jem.144.3.627.

The mediator of cellular immunity. XII. Inhibition of activated T cells by Newcastle disease virus

The mediator of cellular immunity. XII. Inhibition of activated T cells by Newcastle disease virus

D D McGregor et al. J Exp Med. .

Abstract

Newcastle disease virus (NDV) can interact in at least two ways with rat T cells. By adsorbing to circulating lymphocytes, the virus can transiently deflect the cells from lymph nodes and inflammatory exudates induced in the peritoneal cavity. T cells are affected regardless of age, state of activation, or position in the mitotic cycle. The effect is reversible and is mediated not only by infectious (I)-NDV, but also by UV-NDV which cannot achieve a complete replication cycle in eggs. But I-NDV has another lasting effect on activated T cells. It is revealed in the failure of virus-treated thoracic duct lymphocytes to transfer cellular resistance to Listeria monocytogenes, delayed-type hypersensitivity to soluble antigens of the parasite, and the permanent exclusion of labeled S-phase lymphocytes from inflammatory foci. Activated T cells are inhibited by virus multiplicites which have little if any effect upon the proliferative potential of antigen-sensitive T cells or localization of labeled small lymphocytes in lymph nodes. The underlying mechanism has not been determined; however, there are reasons for thinking that NDV has a lethal effect upon activated T cells, because the latter are permissive for virus replication.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1975 Jun 1;141(6):1376-89 - PubMed
    1. Nature. 1976 Jan 29;259(5541):273-81 - PubMed
    1. Cell Immunol. 1975 Jan;15(1):69-81 - PubMed
    1. Scand J Immunol. 1972;1(4):379-91 - PubMed
    1. J Immunol. 1974 Jun;112(6):2176-83 - PubMed

Publication types